Overview Pterygium

Authors

  • Ilmawati Ilmawati Universitas Alkhairaat Palu

DOI:

https://doi.org/10.46799/jhs.v5i8.1340

Keywords:

Pterygium, Surgical Intervention, UV Exposure

Abstract

Pterygium is a wing-shaped fibrovascular growth extending from the conjunctiva onto the cornea. This review aims to provide a comprehensive overview of pterygium, including its etiology, clinical presentation, diagnosis, treatment options, and prognosis. A literature search was conducted using PubMed and Google Scholar databases. Findings suggest that pterygium is primarily associated with UV exposure and occurs more frequently in tropical and subtropical regions. Diagnosis is primarily clinical, with treatment options ranging from conservative management to surgical intervention. While generally benign, pterygium can cause visual disturbances and has a significant recurrence rate post-surgery.

References

Akbari, M. (2022). Update on overview of pterygium and its surgical management. Journal of Population Therapeutics and Clinical Pharmacology= Journal de La Therapeutique Des Populations et de La Pharmacologie Clinique, 29(4), e30–e45.

Alsarhani, W., Alshahrani, S., Showail, M., Alhabdan, N., Alsumari, O., Almalki, A., Alsarhani, A., Alluhaidan, A., & Alqahtani, B. (2021). Characteristics and recurrence of pterygium in Saudi Arabia: a single center study with a long follow‐up. BMC Ophthalmology, 21(1), 207.

Anguria, P., Kitinya, J., Ntuli, S., & Carmichael, T. (2014). The role of heredity in pterygium development. International Journal of Ophthalmology, 7(3), 563.

Baheran, S. S., Alany, R. G., Schwikkard, S., Muen, W., Salman, L. N., Freestone, N., & Al-Kinani, A. A. (2023). Pharmacological treatment strategies of pterygium: drugs, biologics, and novel natural products. Drug Discovery Today, 28(1), 103416.

Chen, B., Fang, X.-W., Wu, M.-N., Zhu, S.-J., Zheng, B., Liu, B.-Q., Wu, T., Hong, X.-Q., Wang, J.-T., & Yang, W.-H. (2023). Artificial intelligence assisted pterygium diagnosis: current status and perspectives. International Journal of Ophthalmology, 16(9), 1386.

Chu, W. K., Choi, H. L., Bhat, A. K., & Jhanji, V. (2020). Pterygium: new insights. Eye, 34(6), 1047–1050.

Chui, J., Coroneo, M. T., Tat, L. T., Crouch, R., Wakefield, D., & Di Girolamo, N. (2011). Ophthalmic pterygium: a stem cell disorder with premalignant features. The American Journal of Pathology, 178(2), 817–827.

Clearfield, E., Muthappan, V., Wang, X., & Kuo, I. C. (2016). Conjunctival autograft for pterygium. Cochrane Database of Systematic Reviews, 2.

Coroneo, M. T. (1993). Pterygium as an early indicator of ultraviolet insolation: a hypothesis. The British Journal of Ophthalmology, 77(11), 734.

Detorakis, E. T., & Spandidos, D. A. (2009). Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives. International Journal of Molecular Medicine, 23(4), 439–447.

Di Girolamo, N., Chui, J., Coroneo, M. T., & Wakefield, D. (2004). Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Progress in Retinal and Eye Research, 23(2), 195–228.

Errais, K., Bouden, J., Mili-Boussen, I., Anane, R., Beltaif, O., & Meddeb Ouertani, A. (2008). Effect of pterygium surgery on corneal topography. European Journal of Ophthalmology, 18(2), 177–181.

Fotouhi, A., Hashemi, H., Khabazkhoob, M., & Mohammad, K. (2009). Prevalence and risk factors of pterygium and pinguecula: the Tehran Eye Study. Eye, 23(5), 1125–1129.

He, S., & Wu, Z. (2022). Biomarkers in the occurrence and development of pterygium. Ophthalmic Research, 65(5), 481–492.

Holland, E. J., Mannis, M. J., & Tan, D. T. H. (2002). Pterygium. Ocular Surface Disease Medical and Surgical Management, 65–89.

Jabbarli, L., Guberina, M., Biewald, E., Flühs, D., Guberina, N., Le Guin, C. H. D., Sauerwein, W., Bornfeld, N., Stuschke, M., & Bechrakis, N. E. (2022). Scleral complications of plaque brachytherapy for pterygium and for uveal melanoma: Response. Clinical & Experimental Ophthalmology, 50(4).

Jc, B. (2010). The science of pterygia. Br J Ophthalmol, 94, 815–820.

Jirsova, K., & Jones, G. L. A. (2017). Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting—a review. Cell and Tissue Banking, 18, 193–204.

Kaufman, S. C., Jacobs, D. S., Lee, W. B., Deng, S. X., Rosenblatt, M. I., & Shtein, R. M. (2013). Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology. Ophthalmology, 120(1), 201–208.

Kodavoor, S. K., Preethi, V., & Dandapani, R. (2021). Profile of complications in pterygium surgery-A retrospective analysis. Indian Journal of Ophthalmology, 69(7), 1697–1701.

Liu, L., Wu, J., Geng, J., Yuan, Z., & Huang, D. (2013). Geographical prevalence and risk factors for pterygium: a systematic review and meta-analysis. BMJ Open, 3(11), e003787.

Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: An expanded sourcebook. sage.

Nemesure, B., Wu, S.-Y., Hennis, A., Leske, M. C., & Group, B. E. S. (2008). Nine-year incidence and risk factors for pterygium in the barbados eye studies. Ophthalmology, 115(12), 2153–2158.

Rezvan, F., Khabazkhoob, M., Hooshmand, E., Yekta, A., Saatchi, M., & Hashemi, H. (2018). Prevalence and risk factors of pterygium: a systematic review and meta-analysis. Survey of Ophthalmology, 63(5), 719–735.

Rojas, J. R., & Malaga, H. (1986). Pterygium in Lima, Peru. Annals of Ophthalmology, 18(4), 147–149.

Saw, S.-M., & Tan, D. (1999). Pterygium: prevalence, demography and risk factors. Ophthalmic Epidemiology, 6(3), 219–228.

Stevenson, L. J., Mackey, D. A., Lingham, G., Burton, A., Brown, H., Huynh, E., Tan, I. J., Franchina, M., Sanfilippo, P. G., & Yazar, S. (2021). Has the sun protection campaign in Australia reduced the need for pterygium surgery nationally? Ophthalmic Epidemiology, 28(2), 105–113.

Sulewski, M., Leslie, L., Liu, S.-H., Ifantides, C., Cho, K., & Kuo, I. C. (2023). Topical ophthalmic anesthetics for corneal abrasions. Cochrane Database of Systematic Reviews, 8.

Taylor, H. R., West, S. K., Rosenthal, F. S., Muñoz, B., Newland, H. S., Abbey, H., & Emmett, E. A. (1988). Effect of ultraviolet radiation on cataract formation. New England Journal of Medicine, 319(22), 1429–1433.

Uba-Obiano, C. U., Nwosu, S. N. N., & Okpala, N. E. (2021). Pterygium in Onitsha, Nigeria. Nigerian Journal of Clinical Practice, 24(8), 1206–1210.

Van Acker, S. I., Van den Bogerd, B., Haagdorens, M., Siozopoulou, V., Ní Dhubhghaill, S., Pintelon, I., & Koppen, C. (2021). Pterygium—the good, the bad, and the ugly. Cells, 10(7), 1567.

Wanzeler, A. C. V., Barbosa, I. A. F., Duarte, B., Borges, D., Barbosa, E. B., Kamiji, D., Huarachi, D. R. G., Melo, M. B. de, & Alves, M. (2019). Mechanisms and biomarker candidates in pterygium development. Arquivos Brasileiros de Oftalmologia, 82(6), 528–536.

Xiradis, N., Li, J. X. L., Ong, R. M., & Francis, I. C. (2022). Scleral complications of plaque brachytherapy for pterygium and for uveal melanoma. Clinical & Experimental Ophthalmology, 50(4).

Zhang, S., Zhang, C., Cai, W., Bai, Y., Callaghan, M., Chang, N., Chen, B., Chen, H., Cheng, L., & Dai, H. (2023). The 2023 China report of the Lancet Countdown on health and climate change: taking stock for a thriving future. The Lancet Public Health, 8(12), e978–e995.

Downloads

Published

2024-08-25